Abstract: In playing multiple hands of baccarat, indication of a first wager and a first selection by a user is received, the first selection for a player win, a banker win or a tie for a first hand of baccarat. Indication of a second wager and a second selection by the user is received, the second selection for a player win, a banker win or a tie for a second hand of baccarat. Input by the user is received, to deal the first hand and the second hand based on the respective first wager and second wager, and on the respective first selection and second selection. In response to the received user input, the first hand and the second hand of baccarat are dealt. For each of the first and second hands, an outcome is determined based on the respective first wager and second wager, and based on the respective first selection and the second selection.

Abstract: The invention provides methods and dosing regimens for eating metastatic stage prostate cancer in a subject using degarelix, as well as related methods of using degarelix in a subject identified as having metastatic stage prostate cancer, and methods of using degarelix to prevent or delay the progression of locally advanced prostate cancer.

Abstract: The invention provides methods and dosing regimens for treating metastatic stage prostate cancer in a subject using degarelix, as well as related methods of using degarelix in a subject identified as having metastatic stage prostate cancer, and methods of using degarelix to prevent or delay the progression of locally advanced prostate cancer.

Abstract: The invention provides methods and dosing regimens for safely and effectively treating androgen-dependent prostate cancer with a gonadotrophin releasing hormone (GnRH) antagonist without causing a testosterone spike and/or other side effect of GnRH agonist therapy such as a urinary tract infection, or an arthralgia-related or cardiovascular side effect.

Abstract: A power amplifier that can provide electrical isolation between an input signal and an amplified output signal avoids isolation between the amplifier output and the load to reduce complexity, component count, cost and size over prior power amplifiers. The power amplifier avoids the use of a power transformer to provide electrical isolation, while maintaining electrical isolation between the amplifier and the input signal to satisfy regulatory requirements. A power converter in the amplifier may be directly connected to input power lines, and provide power factor correction and voltage bus regulation to supply appropriate power to the amplifier. The input signal may be electrically isolated from the amplifier through any suitable isolation including optical isolation or magnetic isolation.

Abstract: A margin violation detector for detecting margin violations of critical paths, a method of monitoring data paths and an IC. In one embodiment, the margin violation detector includes: (1) a monitor flip-flop having a monitor input couplable to a critical path input of a capture flip-flop of a critical path, (2) an exclusive OR gate having a first input couplable to an output of the capture flip-flop and a second input couplable to an output of the monitor flip-flop and (3) a violation detect flip-flop having a detection input couplable to an output of the exclusive OR gate.

Abstract: The invention provides methods and dosing regimens for treating metastatic stage prostate cancer in a subject using degarelix, as well as related methods of using degarelix in a subject identified as having metastatic stage prostate cancer, and methods of using degarelix to prevent or delay the progression of locally advanced prostate cancer.

Abstract: The invention provides methods and dosing regimens for safely and effectively treating androgen-dependent prostate cancer with a gonadotrophin releasing hormone (GnRH) antagonist without causing a testosterone spike and/or other side effect of GnRH agonist therapy such as a urinary tract infection, or an arthralgia-related or cardiovascular side effect.

Abstract: The present invention relates to a method of treating a metastatic prostate cancer patient by administering to said patient an effective amount of a bicalutamide (4?-cyano-??,??,??-trifluoro-3-(4-fluorophenylsulphonyl)-2-hydroxy-2-methylpropiono-m-toluidide) containing formulation capable of delivering at least a mean steady state plasma level of (R)-bicalutamide enantiomer of 40 ?g/ml; and to bicalutamide containing products and formulations capable of delivering the at least mean steady state plasma level of (R)-bicalutamide enantiomer of 40 ?g/ml to a patient in need thereof.

Abstract: The present invention relates to a method of enhancing bone mineral density (BMD) in a patient in need thereof by administration of an effective amount of a non-steroidal anti-androgen compound, preferably bicalutamide. Further aspects of the invention include methods of treating prostate cancer in patients at increased risk of bone fracture and the use of anti-androgen compounds, in particular bicalutamide, in the manufacture of a pharmaceutical product for such purposes.

Abstract: An iron alloy material for brake components comprising substantially perlitic grey iron alloyed with further elements comprising: carbon present in an amount of 3.50-3.70% by weight; vanadium present in an amount of 0.05-0.1% by weight; molybdenum present in an amount of 0.20-0.30% by weight; silicon present in an amount of 1.90-2.0% by weight; manganese present in an amount of 0.55-0.70% by weight; phosphor present in a maximum amount of 0.10% by weight; sulphur present in an amount of 0.08-0.12% by weight; chromium present in an amount of 0.20-0.30% by weight; and copper present in an amount of 0.20-0.30% by weight.

Abstract: A portable, automatic external defibrillator, comprising a plurality of capacitors; a capacitor charging circuit; connections from the capacitors to a patient body; and a plurality of semiconductor switches arranged to connect the capacitors to the charging circuit and to the patient body.

Abstract: An external defibrillator high voltage circuit with a leakage prevention circuit. The high voltage circuit includes first and second output terminals configured for electrical interconnection to electrodes, first and second charge supply terminals configured for interconnection to a charging voltage supply, and a plurality of capacitors. Charging semiconductor switches which are responsive to charge control signals electrically interconnect the capacitors to the charge supply terminals in a parallel circuit to charge the capacitors. Discharging semiconductor switches which are responsive to discharge control signals electrically interconnect the capacitors in a series circuit between the output terminals to generate defibrillation pulses. The discharging switches include at least two switches interconnected to each other at a leakage shunting node and in a series circuit between one of the capacitors and the second output terminal.

Abstract: A portable, automatic external defibrillator, comprising a plurality of capacitors; a capacitor charging circuit; connections from the capacitors to a patient body; and a plurality of semiconductor switches arranged to connect the capacitors to the charging circuit and to the patient body. At least one leakage shunting switch is included to prevent leakage currents from being conducted to the patient.

Abstract: A portable, automatic external defibrillator, comprising a plurality of capacitors; a capacitor charging circuit; connections from the capacitors to a patient body; and a plurality of semiconductor switches arranged to connect the capacitors to the charging circuit and to the patient body.

Abstract: A battery powered cardioverter or defibrillator employing output capacitors for delivery of cardioversion or defibrillation pulses. The capacitors are charged by means of a step-up transformer, coupled and uncoupled from the battery by means of a voltage controlled oscillator which varies its off and on times as a function of the voltage on the battery and the voltage stored on the output capacitor to allow for rapid charging of the capacitor even under conditions of battery depletion. The voltage controlled oscillator is constructed to provide a highly accurate timing signal with a low current drain.

Abstract: A device for preventing snoring of a sleeping person comprises an arrangement (5-9) for detecting snoring sounds and an apparatus (17) controlled by this arrangement and adapted to influence the person to stop snoring. The arrangement has a sound-receiving microphone (5) and at least one frequency filter (6, 8), arranged to deliver signals deriving from sounds with frequencies typical for snoring sounds in order to determine if the present sound derives from snores. The arrangement further comprises a circuit (10-14) for determining if the signals delivered by the microphone are periodically appearing at time intervals, which are typical for snores. The circuit comprises a counter (13) which is arranged to count the number of snores. The arrangement (5-14) of the device is adapted to send activating control pulses to the apparatus when the counter (13) has detected a predetermined number of successive snores with the time intervals.